{"count": 10, "results": [{"_id": "37807930", "pmid": 37807930, "title": "Metformin ointment may relieve hypertrophic and keloid scars.", "journal": "Australas J Dermatol", "authors": ["Hedayatyanfard K", "Niazi S", "Hesami S", "Haddadi NS", "Tavakoli-Far B", "Bayat G", "Doroodgar F", "Niazi F"], "date": "2023-10-09T00:00:00Z", "doi": "10.1111/ajd.14165", "meta_date_publication": "2023 Oct 9", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50272.562, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ointment may relieve @<m>DISEASE_Cardiomyopathy_Hypertrophic</m> @DISEASE_MESH:D002312 @@@hypertrophic@@@ and @DISEASE_Cicatrix @DISEASE_MESH:D002921 @@@keloid scars@@@.", "citations": {"NLM": "Hedayatyanfard K, Niazi S, Hesami S, Haddadi NS, Tavakoli-Far B, Bayat G, Doroodgar F, Niazi F. Metformin ointment may relieve hypertrophic and keloid scars. Australas J Dermatol. 2023 Oct 9;():. PMID: 37807930", "BibTeX": "@article{37807930, title={Metformin ointment may relieve hypertrophic and keloid scars.}, author={Hedayatyanfard K and Niazi S and Hesami S and Haddadi NS and Tavakoli-Far B and Bayat G and Doroodgar F and Niazi F}, journal={Australas J Dermatol}}"}}, {"_id": "34384564", "pmid": 34384564, "title": "Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.", "journal": "J Pharmacol Sci", "authors": ["Sunagawa Y", "Shimizu K", "Katayama A", "Funamoto M", "Shimizu K", "Nurmila S", "Shimizu S", "Miyazaki Y", "Katanasaka Y", "Hasegawa K", "Morimoto T"], "date": "2021-10-01T00:00:00Z", "doi": "10.1016/j.jphs.2021.07.001", "meta_date_publication": "2021 Oct", "meta_volume": "147", "meta_issue": "2", "meta_pages": "169-175", "score": 50260.2, "text_hl": "PURPOSE: The purpose of this study was to investigate whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ leads to suppression of @<m>DISEASE_Cardiomyopathy_Hypertrophic</m> @DISEASE_MESH:D002312 @@@hypertrophic@@@ responses in cardiomyocytes. ", "citations": {"NLM": "Sunagawa Y, Shimizu K, Katayama A, Funamoto M, Shimizu K, Nurmila S, Shimizu S, Miyazaki Y, Katanasaka Y, Hasegawa K, Morimoto T. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes. J Pharmacol Sci. 2021 Oct;147(2):169-175. PMID: 34384564", "BibTeX": "@article{34384564, title={Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.}, author={Sunagawa Y and Shimizu K and Katayama A and Funamoto M and Shimizu K and Nurmila S and Shimizu S and Miyazaki Y and Katanasaka Y and Hasegawa K and Morimoto T}, journal={J Pharmacol Sci}, volume={147}, number={2}, pages={169-175}}"}}, {"_id": "36120288", "pmid": 36120288, "pmcid": "PMC9479636", "title": "Effects of the peripheral CB1 receptor antagonist JD5037 in mono: and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension", "journal": "Front Pharmacol", "authors": ["Remiszewski P", "Pędzińska-Betiuk A", "Mińczuk K", "Schlicker E", "Klimek J", "Dzięcioł J", "Malinowska B"], "date": "2022-09-02T00:00:00Z", "doi": "10.3389/fphar.2022.965613", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "965613", "score": 50243.34, "text_hl": "@CHEMICAL_Monocrotaline @CHEMICAL_MESH:D016686 @@@Monocrotaline@@@ (60 mg/kg) increased right ventricular (RV) systolic pressure (RVSP), led to @DISEASE_Hypertrophy_Right_Ventricular @DISEASE_MESH:D017380 @@@RV and lung hypertrophy and remodeling@@@, and decreased @CHEMICAL_Oxygen @CHEMICAL_MESH:D010100 @@@oxygen@@@ saturation. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ partially restored the @CHEMICAL_Monocrotaline @CHEMICAL_MESH:D016686 @@@monocrotaline@@@-induced effects, i.e., decreased RVSP, increased @CHEMICAL_Oxygen @CHEMICAL_MESH:D010100 @@@oxygen@@@ saturation, and counteracted cardiac fibrotic, @<m>DISEASE_Cardiomyopathy_Hypertrophic</m> @DISEASE_MESH:D002312 @@@hypertrophic@@@, and @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ changes. ", "citations": {"NLM": "Remiszewski P, Pędzińska-Betiuk A, Mińczuk K, Schlicker E, Klimek J, Dzięcioł J, Malinowska B. Effects of the peripheral CB1 receptor antagonist JD5037 in mono: and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension Front Pharmacol. 2022;13():965613. PMID: 36120288", "BibTeX": "@article{36120288, title={Effects of the peripheral CB1 receptor antagonist JD5037 in mono: and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension}, author={Remiszewski P and Pędzińska-Betiuk A and Mińczuk K and Schlicker E and Klimek J and Dzięcioł J and Malinowska B}, journal={Front Pharmacol}, volume={13}, pages={965613}}"}}, {"_id": "36433712", "pmid": 36433712, "title": "Features of BSCL2 related congenital generalized lipodystrophy in China: long-term follow-up of three patients and literature review.", "journal": "J Pediatr Endocrinol Metab", "authors": ["Su X", "Lin Y", "Liu L", "Mei H", "Xu A", "Zeng C", "Sheng H", "Cheng J", "Shao Y", "Zheng R", "Ting TH", "Zhang W", "Li X"], "date": "2022-11-28T00:00:00Z", "doi": "10.1515/jpem-2022-0372", "meta_date_publication": "2023 Jan 27", "meta_volume": "36", "meta_issue": "1", "meta_pages": "74-80", "score": 50227.688, "text_hl": "Although combined therapy with low fat diet and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ maintained normal levels of blood @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ and @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@, this @SPECIES_9606 @@@patient@@@ developed @<m>DISEASE_Cardiomyopathy_Hypertrophic</m> @DISEASE_MESH:D002312 @@@hypertrophic cardiomyopathy@@@ at the age of three. ", "citations": {"NLM": "Su X, Lin Y, Liu L, Mei H, Xu A, Zeng C, Sheng H, Cheng J, Shao Y, Zheng R, Ting TH, Zhang W, Li X. Features of BSCL2 related congenital generalized lipodystrophy in China: long-term follow-up of three patients and literature review. J Pediatr Endocrinol Metab. 2023 Jan 27;36(1):74-80. PMID: 36433712", "BibTeX": "@article{36433712, title={Features of BSCL2 related congenital generalized lipodystrophy in China: long-term follow-up of three patients and literature review.}, author={Su X and Lin Y and Liu L and Mei H and Xu A and Zeng C and Sheng H and Cheng J and Shao Y and Zheng R and Ting TH and Zhang W and Li X}, journal={J Pediatr Endocrinol Metab}, volume={36}, number={1}, pages={74-80}}"}}, {"_id": "30873028", "pmid": 30873028, "pmcid": "PMC6400884", "title": "Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction", "journal": "Front Pharmacol", "authors": ["Loi H", "Boal F", "Tronchere H", "Cinato M", "Kramar S", "Oleshchuk O", "Korda M", "Kunduzova O"], "date": "2019-02-27T00:00:00Z", "doi": "10.3389/fphar.2019.00154", "meta_date_publication": "2019", "meta_volume": "10", "meta_issue": "", "meta_pages": "154", "score": 50058.82, "text_hl": "In the first set of experiments, we investigated whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ affects metabolic- or oxidative stress-induced @<m>DISEASE_Cardiomyopathy_Hypertrophic</m> @DISEASE_MESH:D002312 @@@hypertrophic@@@ responses in vitro. ", "citations": {"NLM": "Loi H, Boal F, Tronchere H, Cinato M, Kramar S, Oleshchuk O, Korda M, Kunduzova O. Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction Front Pharmacol. 2019;10():154. PMID: 30873028", "BibTeX": "@article{30873028, title={Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction}, author={Loi H and Boal F and Tronchere H and Cinato M and Kramar S and Oleshchuk O and Korda M and Kunduzova O}, journal={Front Pharmacol}, volume={10}, pages={154}}"}}, {"_id": "31557380", "pmid": 31557380, "pmcid": "PMC6826125", "title": "Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial", "journal": "Aging Cell", "authors": ["Walton RG", "Dungan CM", "Long DE", "Tuggle SC", "Kosmac K", "Peck BD", "Bush HM", "Villasante Tezanos AG", "McGwin G", "Windham ST", "Ovalle F", "Bamman MM", "Kern PA", "Peterson CA"], "date": "2019-12-01T00:00:00Z", "doi": "10.1111/acel.13039", "meta_date_publication": "2019 Dec", "meta_volume": "18", "meta_issue": "6", "meta_pages": "e13039", "score": 50052.113, "text_hl": "These results underscore the benefits of PRT in older adults, but @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ negatively impacts the @<m>DISEASE_Cardiomyopathy_Hypertrophic</m> @DISEASE_MESH:D002312 @@@hypertrophic@@@ response to resistance training in healthy older individuals. ", "citations": {"NLM": "Walton RG, Dungan CM, Long DE, Tuggle SC, Kosmac K, Peck BD, Bush HM, Villasante Tezanos AG, McGwin G, Windham ST, Ovalle F, Bamman MM, Kern PA, Peterson CA. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial Aging Cell. 2019 Dec;18(6):e13039. PMID: 31557380", "BibTeX": "@article{31557380, title={Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial}, author={Walton RG and Dungan CM and Long DE and Tuggle SC and Kosmac K and Peck BD and Bush HM and Villasante Tezanos AG and McGwin G and Windham ST and Ovalle F and Bamman MM and Kern PA and Peterson CA}, journal={Aging Cell}, volume={18}, number={6}, pages={e13039}}"}}, {"_id": "24444314", "pmid": 24444314, "pmcid": "PMC3981893", "title": "Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria", "journal": "J Cell Mol Med", "authors": ["Hernández JS", "Barreto-Torres G", "Kuznetsov AV", "Khuchua Z", "Javadov S"], "date": "2014-04-01T00:00:00Z", "doi": "10.1111/jcmm.12220", "meta_date_publication": "2014 Apr", "meta_volume": "18", "meta_issue": "4", "meta_pages": "709-20", "score": 50047.297, "text_hl": "Accordingly, new studies using cultured cardiomyocytes are required to establish whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exerts a direct anti-@<m>DISEASE_Cardiomyopathy_Hypertrophic</m> @DISEASE_MESH:D002312 @@@hypertrophic@@@ effect on these cells.", "citations": {"NLM": "Hernández JS, Barreto-Torres G, Kuznetsov AV, Khuchua Z, Javadov S. Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria J Cell Mol Med. 2014 Apr;18(4):709-20. PMID: 24444314", "BibTeX": "@article{24444314, title={Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria}, author={Hernández JS and Barreto-Torres G and Kuznetsov AV and Khuchua Z and Javadov S}, journal={J Cell Mol Med}, volume={18}, number={4}, pages={709-20}}"}}, {"_id": "24302978", "pmid": 24302978, "pmcid": "PMC3840053", "title": "Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms", "journal": "PLoS One", "authors": ["Picatoste B", "Ramírez E", "Caro-Vadillo A", "Iborra C", "Ares-Carrasco S", "Egido J", "Tuñón J", "Lorenzo O"], "date": "2013-10-21T00:00:00Z", "doi": "10.1371/journal.pone.0078330", "meta_date_publication": "2013", "meta_volume": "8", "meta_issue": "10", "meta_pages": "e78330", "score": 50046.676, "text_hl": "Direct protective effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on cardiac cells", "citations": {"NLM": "Picatoste B, Ramírez E, Caro-Vadillo A, Iborra C, Ares-Carrasco S, Egido J, Tuñón J, Lorenzo O. Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms PLoS One. 2013;8(10):e78330. PMID: 24302978", "BibTeX": "@article{24302978, title={Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms}, author={Picatoste B and Ramírez E and Caro-Vadillo A and Iborra C and Ares-Carrasco S and Egido J and Tuñón J and Lorenzo O}, journal={PLoS One}, volume={8}, number={10}, pages={e78330}}"}}, {"_id": "26998282", "pmid": 26998282, "title": "LKB1/AMPK pathway mediates resistin-induced cardiomyocyte hypertrophy in H9c2 embryonic rat cardiomyocytes.", "journal": "Biomed Rep", "authors": ["Liu P", "Cheng GC", "Ye QH", "Deng YZ", "Wu L"], "date": "2016-03-01T00:00:00Z", "doi": "10.3892/br.2016.593", "meta_date_publication": "2016 Mar", "meta_volume": "4", "meta_issue": "3", "meta_pages": "387-391", "score": 50040.18, "text_hl": "Treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformine@@@ attenuated these effects of @GENE_RETN @GENE_246250 @@@resistin@@@. ", "citations": {"NLM": "Liu P, Cheng GC, Ye QH, Deng YZ, Wu L. LKB1/AMPK pathway mediates resistin-induced cardiomyocyte hypertrophy in H9c2 embryonic rat cardiomyocytes. Biomed Rep. 2016 Mar;4(3):387-391. PMID: 26998282", "BibTeX": "@article{26998282, title={LKB1/AMPK pathway mediates resistin-induced cardiomyocyte hypertrophy in H9c2 embryonic rat cardiomyocytes.}, author={Liu P and Cheng GC and Ye QH and Deng YZ and Wu L}, journal={Biomed Rep}, volume={4}, number={3}, pages={387-391}}"}}, {"_id": "29483803", "pmid": 29483803, "title": "A case of Donohue syndrome \"Leprechaunism\" with a novel mutation in the insulin receptor gene.", "journal": "Turk Pediatri Ars", "authors": ["Kirel B", "Bozdağ Ö", "Köşger P", "Aydoğdu SD", "Alıncak E", "Tekin N"], "date": "2017-12-01T00:00:00Z", "doi": "10.5152/TurkPediatriArs.2017.3193", "meta_date_publication": "2017 Dec", "meta_volume": "52", "meta_issue": "4", "meta_pages": "226-230", "score": 50031.562, "text_hl": "However, severe @<m>DISEASE_Cardiomyopathy_Hypertrophic</m> @DISEASE_MESH:D002312 @@@hypertrophic obstructive cardiomyopathy@@@ and severe @DISEASE_Malnutrition @DISEASE_MESH:D044342 @@@malnutrition@@@ developed. ", "citations": {"NLM": "Kirel B, Bozdağ Ö, Köşger P, Aydoğdu SD, Alıncak E, Tekin N. A case of Donohue syndrome \"Leprechaunism\" with a novel mutation in the insulin receptor gene. Turk Pediatri Ars. 2017 Dec;52(4):226-230. PMID: 29483803", "BibTeX": "@article{29483803, title={A case of Donohue syndrome \"Leprechaunism\" with a novel mutation in the insulin receptor gene.}, author={Kirel B and Bozdağ Ö and Köşger P and Aydoğdu SD and Alıncak E and Tekin N}, journal={Turk Pediatri Ars}, volume={52}, number={4}, pages={226-230}}"}}]}